ES368198A1 - Antibiotic complex - Google Patents

Antibiotic complex

Info

Publication number
ES368198A1
ES368198A1 ES368198A ES368198A ES368198A1 ES 368198 A1 ES368198 A1 ES 368198A1 ES 368198 A ES368198 A ES 368198A ES 368198 A ES368198 A ES 368198A ES 368198 A1 ES368198 A1 ES 368198A1
Authority
ES
Spain
Prior art keywords
axenomycine
meoh
spectrum
complex
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES368198A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of ES368198A1 publication Critical patent/ES368198A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F7/00Shielded cells or rooms
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21HOBTAINING ENERGY FROM RADIOACTIVE SOURCES; APPLICATIONS OF RADIATION FROM RADIOACTIVE SOURCES, NOT OTHERWISE PROVIDED FOR; UTILISING COSMIC RADIATION
    • G21H5/00Applications of radiation from radioactive sources or arrangements therefor, not otherwise provided for 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The novel antibiotic axenomycine, also named F.I. 2604, is produced by cultivating Streptomyces lisandri n. sp., I.P.V 1951, I.M.R.U. 3935, I.M.I. 137178, or an axenomycine-producing strain thereof, under aerobic conditions in an aqueous medium containing assimilable sources of carbon and nitrogen and mineral salts, and isolating the axenomycine from the cultivated medium. The cultivation is preferably carried out at 23-37 C. and pH 6-9 for 60-160 hours. Axenomycine is a complex of two components, axenomycines A and B. The complex and its components are amorphous yellowish-white substances, soluble in methyl, ethyl and propyl alcohol, sparingly soluble in water, ethyl acetate, acetone and chloroform, and insoluble in benzene and petroleum ether. They reduce Fehling's solution and ammoniacal silver nitrate, give a positive reaction with tetrazole blue and a weakly positive Molisch reaction. They give negative reactions with ferric chloride, the aniline phthalate test for aldoses and the naphthoresorcinol test for ketoses. Axenomycine A has the following characteristics: elementary analysis, 61.74% C, 8.52% H, 28.87% O molecular weight 1451.3 melting point 127-142 C. to give a transparent reddish gel [[alpha]]23 D = + 10À5 (C = 0.9 in MeOH) Rf = 0.49 on silica gel at pH 7.0 using n. butanol: acetic acid: water = 4: 0.5: 1 U.V. spectrum in MeOH has absorption peaks at 249, 254 and 330 mÁ and a shoulder at 265-268 mÁ I.R. spectrum in a KBr disc has peaks at 2.94, 3À44, 5.78, 6.00, 6.16, 6.24, 6.88, 7.25, 7.41, 8.61, 8.85, 9.35, 10.00, 10.40, 10.95, 11.8 and 12À5 Á. Axenomycine B has the characteristics: elementary analysis, 62.8% C., 8.58% H, 27.8% O molecular weight 1330.2 melting point 122- 140 C. [[alpha]]23 D = + 5 (C = 0.9 in MeOH) Rf = 0À61 on silica gel at pH 7À0 using n. butanol: acetic acid: water = 4À0 : 0À5: 1 U.V. spectrum in MeOH has absorption peaks at 249, 254 and 330 mÁ and a shoulder at 265- 268 mÁ I.R. spectrum in a KBr disc has peaks at 2.94, 3À40, 5.82, 6.00, 6.16, 6.24, 6.86, 7.25, 7.41, 8.60, 8.85, 9.35, 10.00, 10.40, 10.98, 11.8, and 12À5 Á. The antibiotic complex may be extracted from the separated mycelium with e.g. methanol, or from the whole broth with a water-immiscible solvent, and purified by precipitation with a non-solvent followed by counter-current distribution. The two components may be separated by chromatography on a silica gel column at pH 7.0, developing with BuOH: HAc: H 2 O, 4: 0À5: 1 by volume. The antibiotics have anthelmintic, antiprotozoal and antifungal activity. Pharmaceutical compositions comprise axenomycine complex or one of its components A or B together with a pharmaceutically acceptable vehicle.
ES368198A 1968-06-11 1969-06-10 Antibiotic complex Expired ES368198A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1757068 1968-06-11

Publications (1)

Publication Number Publication Date
ES368198A1 true ES368198A1 (en) 1971-05-01

Family

ID=11150434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES368198A Expired ES368198A1 (en) 1968-06-11 1969-06-10 Antibiotic complex

Country Status (16)

Country Link
AT (1) AT285817B (en)
BE (1) BE734341A (en)
BR (1) BR6909580D0 (en)
CH (1) CH506619A (en)
CS (1) CS178807B2 (en)
DE (1) DE1929107C3 (en)
DK (1) DK120716B (en)
ES (1) ES368198A1 (en)
FR (1) FR2010640A1 (en)
GB (1) GB1219709A (en)
IE (1) IE32866B1 (en)
IL (1) IL32358A (en)
NL (1) NL153271B (en)
NO (1) NO127927B (en)
SE (1) SE354483B (en)
YU (1) YU34212B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1044819B (en) * 1970-05-04 1980-04-21 Farmaceutici Italia ANTIBIOTIC COMPOUND

Also Published As

Publication number Publication date
DE1929107C3 (en) 1978-10-12
NO127927B (en) 1973-09-03
NL6908269A (en) 1969-12-15
IE32866B1 (en) 1973-12-28
DK120716B (en) 1971-07-05
IL32358A (en) 1972-11-28
CH506619A (en) 1971-04-30
GB1219709A (en) 1971-01-20
BE734341A (en) 1969-12-10
IL32358A0 (en) 1969-08-27
FR2010640A1 (en) 1970-02-20
YU34212B (en) 1979-02-28
DE1929107A1 (en) 1970-02-19
IE32866L (en) 1969-12-11
CS178807B2 (en) 1977-10-31
BR6909580D0 (en) 1973-04-19
DE1929107B2 (en) 1978-02-09
YU144469A (en) 1978-06-30
AT285817B (en) 1970-11-10
NL153271B (en) 1977-05-16
SE354483B (en) 1973-03-12

Similar Documents

Publication Publication Date Title
Grove et al. The cytotoxicity of some transformation products of diacetoxyscirpenol
US3780173A (en) Partricin methyl ester
Hooper et al. Sesquiterpene hydroquinones from the South African soft coral Alcyonium fauri
ES334165A1 (en) Antibiotic sl 2266
ES368198A1 (en) Antibiotic complex
GB1349179A (en) Antibiotic
GB1038242A (en) Bleomycin and processes for preparation thereof
Kettner et al. Dactylarin, a new antiprotozoal antibiotic from Dactylaria lutea
SE328254B (en)
KITAGAWA et al. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin
IL42685A (en) Antibiotic a-2315 and process for preparation thereof
Sano et al. Iyomycin, A New Antitumor Antibiotic from Streptomyces. III Isolation and Properties of Iyomycin B
TAKANI et al. Studies on constituents of medicinal plants. XIX. Constituents of Schizandra nigra Max.(3)
US3089816A (en) Lemacidine and process for its manufacture
ES341402A1 (en) Antibiotics of agricultural fungicides,polyoxins d,e,f,g and h
GB1378414A (en) Antibiotic compound and its preparation
GB1314983A (en) Antibiotic substance and method of producing same
ES361544A1 (en) Process for the production of a new antibiotic sf-733 substance
GB1356723A (en) Antibiotic sf-1293 substance and its production and uses
GB1322797A (en) Antibiotic janiemycin
GB1389065A (en) Process for isolating an antibiotic with both antiprotozoan and cancerostatic activities
GB1285163A (en) Antibiotic compound
GB1212741A (en) A method for producing an antibiotic b-2847
JPS5659777A (en) Novel antibiotic, xk-213 and its preparation
GB1181605A (en) Libanomycin Antibiotics